BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7874873)

  • 1. Laboratory monitoring of oral anticoagulant therapy.
    Poller L; Samama M
    Clin Lab Med; 1994 Dec; 14(4):813-23. PubMed ID: 7874873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control and oral anticoagulation.
    Preston FE
    Thromb Haemost; 1995 Jul; 74(1):515-20. PubMed ID: 8578516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status of standardization in coagulation assays for control of oral anticoagulation.
    Dati F; Becker U
    Behring Inst Mitt; 1988 Apr; (82):309-24. PubMed ID: 3408455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of anticoagulant control.
    Poller L
    Ric Clin Lab; 1978; 8(4):237-47. PubMed ID: 734318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodology.
    Barbui T; Finazzi G; Remuzzi A
    Thromb Haemost; 1995 Jul; 74(1):511-4. PubMed ID: 8578515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin.
    Brophy MT; Fiore LD; Lau J; Headley E; Allen M; Deykin D
    Arch Pathol Lab Med; 1993 Jun; 117(6):618-21. PubMed ID: 8503734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standardization problems in the monitoring of oral anticoagulants by Quick's thromboplastin time: an attempt to determine the state of the problem in Switzerland].
    Marti P; Beck EA
    Schweiz Med Wochenschr; 1983 Oct; 113(43):1593-7. PubMed ID: 6648436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of the treatment with oral anticoagulants and prothrombin time].
    Marzouka E
    Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
    Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
    Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of laboratory monitoring in oral anticoagulant therapy].
    D'Angelo G; Calvano D; Giardini C
    Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
    Tripodi A; Chantarangkul V; Braga M; Poller L; ten Cate JW; van den Besselaar AM; Mannucci PM
    Thromb Haemost; 1994 Aug; 72(2):261-7. PubMed ID: 7831663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulant therapy and its control: an international survey.
    Lam-Po-Tang PR; Poller L
    Thromb Diath Haemorrh; 1975 Nov; 34(2):419-25. PubMed ID: 1198405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations.
    Loeliger EA; Meuwisse-Braun JB; Muis H; Buitendijk FJ; Veltkamp JJ; Hemker HC
    Thromb Diath Haemorrh; 1970 Jun; 23(3):569-84. PubMed ID: 5432194
    [No Abstract]   [Full Text] [Related]  

  • 17. Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation.
    Kitchen S; Walker ID; Woods TA; Preston FE
    Thromb Haemost; 1994 Sep; 72(3):426-9. PubMed ID: 7855795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Greaves M;
    Thromb Haemost; 2002 Jan; 87(1):163-4. PubMed ID: 11848446
    [No Abstract]   [Full Text] [Related]  

  • 19. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 20. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.